Expression of CXCR6 on CD8+ T cells was up-regulated in allograft rejection

Transplant Immunology

Volumn 22, Issue 3-4, 2010, Pages 179-183

  Jiang, Xiaofeng ^a   Sun, Wenyu ^a   Zhu, Lei ^a   Guo, Dawei ^a   Jiang, Honglei ^a   Ma, Dongyan ^a   Jin, Junzhe ^a   Zhao, Yu ^a   Liang, Jian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Allograft rejection; CD8+ T cells; Chemokine; CXCL16

Indexed keywords

CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; CYCLOSPORIN A; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; GRAFT SURVIVAL; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME; UPREGULATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOPHENOTYPING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CXCR; SPLEEN; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 77951629975     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.12.001     Document Type: Article

References (43)

1. Kobayashi Y. Neutrophil infiltration and chemokines. Crit Rev Immunol 2006, 26:307-316.
2. Luther S.A., Cyster J.G. Chemokines as regulators of T cell differentiation. Nat Immunol 2001, 2:102-107.
3. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2001, 2:123-128.
4. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242.
5. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
6. Mehrad B., Keane M.P., Strieter R.M. Chemokines as mediators of angiogenesis. Thromb Haemost 2007, 97:755-762.
7. DeVries M.E., Hosiawa K.A., Cameron C.M., Bosinger S.E., Persad D., Kelvin A.A., et al. The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. Semin Immunol 2003, 15:33-48.
8. Hancock W.W., Wang L., Ye Q., Han R., Lee I. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003, 15:479-486.
9. Merani S., Truong W.W., Hancock W., Anderson C.C., Shapiro A.M. Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction. Cell Transplant 2006, 15:295-309.
10. Allen S.J., Crown S.E., Handel T.M. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007, 25:787-820.
11. Matloubian M., David A., Engel S., Ryan J.E., Cyster J.G. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol 2000, 1:298-304.
12. Wilbanks A., Zondlo S.C., Murphy K., Mak S., Soler D., Langdon P., et al. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J Immunol 2001, 166:5145-5154.
13. Shimaoka T., Kume N., Minami M., Hayashida K., Kataoka H., Kita T., et al. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J Biol Chem 2000, 275:40663-40666.
14. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644.
15. Shimaoka T., Nakayama T., Fukumoto N., Kume N., Takahashi S., Yamaguchi J., et al. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J Leukoc Biol 2004, 75:267-274.
16. Loetscher M., Amara A., Oberlin E., Brass N., Legler D., Loetscher P., et al. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr Biol 1997, 7:652-660.
17. Liao F., Alkhatib G., Peden K.W., Sharma G., Berger E.A., Farber J.M. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 1997, 185:2015-2023.
18. Deng H.K., Unutmaz D., KewalRamani V.N., Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997, 388:296-300.
19. Hedman M., Faresjo M., Axelsson S., Ludvigsson J., Casas R. Impaired CD4+ and CD8+ T cell phenotype and reduced chemokine secretion in recent-onset type diabetic children. Clin Exp Immunol 2008, 153:360-368.
20. Kim C.H., Kunkel E.J., Boisvert J., Johnston B., Campbell J.J., Genovese M.C., et al. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J Clin Invest 2001, 107:595-601.
21. Nakayama T., Hieshima K., Izawa D., Tatsumi Y., Kanamaru A., Yoshie O. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues. J Immunol 2003, 170:1136-1140.
22. Matsumura S., Wang B., Kawashima N., Braunstein S., Badura M., Cameron T.O., et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J Immunol 2008, 181:3099-3107.
23. Sato T., Thorlacius H., Johnston B., Staton T.L., Xiang W., Littman D.R., et al. Role for CXCR6 in recruitment of activated CD8+ lymphocytes to inflamed liver. J Immunol 2005, 74:277-283.
24. Koizumi K., Hojo S., Akashi T., Yasumoto K., Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007, 8:1652-1658.
25. Freeman C.M., Curtis J.L., Chensue S.W. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am J Pathol 2007, 171:767-776.
26. Schramme A., Abdel-Bakky M.S., Gutwein P., Obermüller N., Baer P.C., Hauser I.A., et al. Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney. Kidney Int 2008, 74:328-338.
27. Corry R.J., Winn H.J., Russell P.S. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973, 16:343-350.
28. Horuk R., Clayberger C., Krensky A.M., Wang Z., Grone H.J., Weber C., et al. A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection. J Biol Chem 2001, 276:4199-4204.
29. Gao W., Topham P.S., King J.A., Smiley S.T., Csizmadia V., Lu B., et al. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest 2000, 105:35-44.
30. Haskell C.A., Hancock W.W., Salant D.J., Gao W., Csizmadia V., Peters W., et al. Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest 2001, 108:679-688.
31. Wuttge D.M., Zhou X., Sheikine Y., Wagsater D., Stemme V., Hedin U., et al. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2004, 24:750-755.
32. Zernecke A., Shagdarsuren E., Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 2008, 28:1897-1908.
33. Sheikine Y., Sirsjo A. CXCL16/SR-PSOX-A friend or a foe in atherosclerosis?. Atherosclerosis 2008, 197:487-495.
34. Fukumoto N., Shimaoka T., Fujimura H., Sakoda S., Tanaka M., Kita T., et al. Critical roles of CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis. J Immunol 2004, 173:1620-1627.
35. Xu H.B., Gong Y.P., Cheng J., Chu Y.W., Xiong S.D. CXCL16 participates in pathogenesis of immunological liver injury by regulating T lymphocyte infiltration in liver tissue. World J Gastroenterol 2005, 11:4979-4985.
36. Hojo S., Koizumi K., Tsuneyama K., Arita Y., Cui Z., Shinohara K., et al. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res 2007, 67:4725-4731.
37. Meijer J., Ogink J., Kreike B., Nuyten D., de Visser K.E., Roos E. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Cancer Res 2008, 68:4701-4708.
38. Gutwein P., Schramme A., Sinke N., Abdel-Bakky M.S., Voss B., Obermüller N., et al. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. Eur J Cancer 2009, 45:478-489.
39. Germanov E., Veinotte L., Cullen R., Chamberlain E., Butcher E.C., Johnston B. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells. J Immunol 2008, 181:81-91.
40. Jiang X., Shimaoka T., Kojo S., Harada M., Watarai H., Wakao H., et al. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol 2005, 175:2051-2055.
41. + T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler Thromb Vasc Biol 2004, 24:282-287.
42. Mamoune A., Durand V., Le Goff P., Pennec Y.L., Youinou P., Le Corre R. Abnormal distribution of CD45 isoforms expressed by CD4+ and CD8+ T cells in rheumatoid arthritis. Histol Histopathol 2000, 15:587-591.
43. Dijke I.E., Weimar W., Baan C.C. Regulatory T cells after organ transplantation: where does their action take place?. Hum Immunol 2008, 69:389-398.